• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Imposter among us: field cancerization in the bladder.

作者信息

Rodden Daniel J, Chung Ella H, Pittie Rea, Miyamoto David T

机构信息

Krantz Family Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

出版信息

Transl Androl Urol. 2024 Jul 31;13(7):1319-1323. doi: 10.21037/tau-24-8. Epub 2024 Jul 4.

DOI:10.21037/tau-24-8
PMID:39100848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11291423/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dfa/11291423/3aaf4df50465/tau-13-07-1319-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dfa/11291423/3aaf4df50465/tau-13-07-1319-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dfa/11291423/3aaf4df50465/tau-13-07-1319-f1.jpg

相似文献

1
Imposter among us: field cancerization in the bladder.我们之中的冒名顶替者：膀胱中的场癌化
Transl Androl Urol. 2024 Jul 31;13(7):1319-1323. doi: 10.21037/tau-24-8. Epub 2024 Jul 4.
2
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer.肿瘤微环境中的场癌变与膀胱癌的肿瘤发生、T 细胞耗竭和临床结局相关。
Eur Urol. 2024 Jan;85(1):82-92. doi: 10.1016/j.eururo.2023.07.014. Epub 2023 Sep 16.
3
TOX-expressing terminally exhausted tumor-infiltrating CD8 T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer.在膀胱癌中，共阻断 PD-1 和 TIGIT 可重新激活表达 TOX 的终末耗竭肿瘤浸润 CD8 T 细胞。
Cancer Lett. 2021 Feb 28;499:137-147. doi: 10.1016/j.canlet.2020.11.035. Epub 2020 Nov 27.
4
Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout.程序性细胞死亡蛋白 1 阻断与 CRISPR-Cas9 介导的长链非编码 RNA 尿路上皮癌相关 1 敲除的合理联合对膀胱癌的协同抗肿瘤作用。
Hum Gene Ther. 2018 Dec;29(12):1352-1363. doi: 10.1089/hum.2018.048. Epub 2018 Nov 19.
5
Cancer cells accelerate exhaustion of persistently activated mouse CD4 T cells.癌细胞加速持续活化的小鼠CD4 T细胞耗竭。
Oncoimmunology. 2025 Dec;14(1):2521392. doi: 10.1080/2162402X.2025.2521392. Epub 2025 Jun 19.
6
New insights into T-cell exhaustion in liver cancer: from mechanism to therapy.肝癌中 T 细胞耗竭的新见解：从机制到治疗。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12543-12560. doi: 10.1007/s00432-023-05083-5. Epub 2023 Jul 9.
7
The impact of imposter syndrome on ego integrity and gender dynamics among aging nurses: A mixed-methods study.冒名顶替综合症对老年护士自我完整性和性别动态的影响：一项混合方法研究。
Geriatr Nurs. 2025 Jul 4;65:103467. doi: 10.1016/j.gerinurse.2025.103467.
8
Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features.与放疗相关的膀胱癌预后不良的定义与临床基因组特征有关。
Cancer Res Commun. 2024 Sep 1;4(9):2320-2334. doi: 10.1158/2767-9764.CRC-24-0352.
9
Galectin-9 and Tim-3 in gastric cancer: a checkpoint axis driving T cell exhaustion and Treg-mediated immunosuppression independently of anti-PD-1 blockade.胃癌中的半乳糖凝集素-9和Tim-3：一个驱动T细胞耗竭和调节性T细胞介导的免疫抑制的检查点轴，独立于抗程序性死亡蛋白1阻断作用
Front Immunol. 2025 Jul 1;16:1600792. doi: 10.3389/fimmu.2025.1600792. eCollection 2025.
10
PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics.程序性死亡受体1配体（PD-L1）诊断测试：评分算法和测试验证指标的系统文献综述
Diagn Pathol. 2018 Feb 9;13(1):12. doi: 10.1186/s13000-018-0689-9.

引用本文的文献

1
Comparison of microRNA-21 expression in bladder cancer tumor with normal-appearing adjacent tissue and healthy controls.膀胱癌肿瘤组织与外观正常的相邻组织及健康对照中微小RNA-21表达的比较。
Int Urol Nephrol. 2025 Jun 13. doi: 10.1007/s11255-025-04581-4.

本文引用的文献

1
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment.非肌层浸润性膀胱癌的诊断与治疗：美国泌尿外科学会/泌尿外科学会指南：2024年修订版
J Urol. 2024 Apr;211(4):533-538. doi: 10.1097/JU.0000000000003846. Epub 2024 Jan 24.
2
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group.膀胱癌的定义、终点和临床试验设计：癌症免疫治疗学会和国际膀胱癌协会的建议。
J Clin Oncol. 2023 Dec 10;41(35):5437-5447. doi: 10.1200/JCO.23.00307. Epub 2023 Oct 4.
3
Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer.
肿瘤微环境中的场癌变与膀胱癌的肿瘤发生、T 细胞耗竭和临床结局相关。
Eur Urol. 2024 Jan;85(1):82-92. doi: 10.1016/j.eururo.2023.07.014. Epub 2023 Sep 16.
4
Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs.中高危非肌层浸润性膀胱癌：流行病学、疾病负担及未满足需求概述
Front Oncol. 2023 Jun 2;13:1170124. doi: 10.3389/fonc.2023.1170124. eCollection 2023.
5
Immune Checkpoint Inhibitor Toxicity Management in Non-muscle-invasive Bladder Cancer: What Urologists Need To Know.免疫检查点抑制剂在非肌肉浸润性膀胱癌中的毒性管理：泌尿科医生需要知道什么。
Eur Urol Focus. 2023 Jul;9(4):579-581. doi: 10.1016/j.euf.2023.04.011. Epub 2023 May 16.
6
Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers.循环肿瘤细胞和循环肿瘤 DNA 在泌尿系统癌症中的应用。
Urol Clin North Am. 2023 Feb;50(1):109-114. doi: 10.1016/j.ucl.2022.09.010.
7
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non-muscle-invasive Bladder Cancer.高 T 细胞耗竭和尿肿瘤 DNA 水平与非肌肉浸润性膀胱癌患者卡介苗失败相关。
Eur Urol. 2022 Dec;82(6):646-656. doi: 10.1016/j.eururo.2022.09.008. Epub 2022 Oct 7.
8
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.NCCN 指南®洞察：膀胱癌，第 2.2022 版。
J Natl Compr Canc Netw. 2022 Aug;20(8):866-878. doi: 10.6004/jnccn.2022.0041.
9
The origin of bladder cancer from mucosal field effects.膀胱癌源于黏膜场效应。
iScience. 2022 Jun 7;25(7):104551. doi: 10.1016/j.isci.2022.104551. eCollection 2022 Jul 15.
10
Quality of life patterns and its association with predictors among non-muscle invasive bladder cancer survivors: A latent profile analysis.非肌肉浸润性膀胱癌幸存者的生活质量模式及其与预测因素的关联：一项潜在剖面分析。
Asia Pac J Oncol Nurs. 2022 Apr 12;9(6):100063. doi: 10.1016/j.apjon.2022.04.002. eCollection 2022 Jun.